Diagnostics News and Research

RSS

Rigontec raises €4.8 million in second closing of Series A financing round

Rigontec GmbH, a privately held biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of cancer and viral diseases, today announces it has raised €4.8 million in a second closing of its Series A financing round from Forbion Capital Partners, a Dutch life-sciences venture capital firm, and Sunstone Capital, a Copenhagen based venture capital investor.

24 Mar 2015

Researchers use genetic information to track the fatal spread of multidrug-resistant TB

Scientists have for the first time used DNA sequencing to trace the fatal spread of multidrug-resistant tuberculosis between patients in the UK.

24 Mar 2015

Scientists use DNA sequencing to trace the spread of drug-resistant TB

Scientists have for the first time used DNA sequencing to trace the fatal spread of multidrug-resistant tuberculosis between patients in the UK.

24 Mar 2015

Newly identified proteins could shed light on the mechanisms of ALS

Where ALS comes from and how it progresses are mysteries that continue to vex medical science. But recent research at Sweden's KTH Royal Institute of Technology has found three proteins that could shed some light on the mechanisms behind this deadly disease.

24 Mar 2015

Association for Molecular Pathology submits written comments to FDA on NGS regulation

The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, submitted written comments on March 20 to the U.S. Food and Drug Administration (FDA) in response to the agency's request for feedback in association with its February 20, 2015 public workshop entitled, "Optimizing FDA's Regulatory Oversight of Next Generation Sequencing Diagnostic Tests."

24 Mar 2015

Globavir, BioManguinhos partner to jointly evaluate PanGlob RT-PCR Dengue diagnostic assay

Globavir Biosciences, Inc., a biotechnology company developing diagnostic and therapeutic technologies to treat infectious diseases, has announced a partnership with BioManguinhos, a division of the Oswaldo Cruz Foundation, for a joint evaluation of Globavir's PanGlob RT-PCR Dengue diagnostic assay.

23 Mar 2015

Genomic Health presents 11 studies demonstrating value of Oncotype DX breast cancer test

Genomic Health today announced the presentation of 11 studies with the Oncotype DX breast cancer test at the 14th St. Gallen Breast Cancer Conference in Vienna, Austria. Studies presented include results from a real-life observational study in Ireland demonstrating significant reductions in chemotherapy and resulting cost savings when the test is used in early stage breast cancer.

23 Mar 2015

MEDITE announces granting of German priority patent for Histology 'Lab-in-one Automation' System

MEDITE Cancer Diagnostics, Inc., specializing in the development, manufacturing and marketing of superior molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and related diseases announced the recent decision of the German Patent Register to grant MEDITE the German priority patent for its Histology "Lab-in-one Automation" System.

22 Mar 2015

Sandia biosciences technologies could soon find their way into doctors' offices

Technologies developed in Sandia National Laboratories' biosciences program could soon find their way into doctors' offices -- devices like wearable microneedles that continuously analyze electrolyte levels and a lab-on-a-disk that can test a drop of blood for 64 different diseases in minutes.

20 Mar 2015

INTEGRA Biosciences announces opening of German subsidiary

Following on from the successful launch of subsidiaries in France, the UK and the USA - INTEGRA Biosciences has announced the opening in January 2015 of a new organisation based in Konstanz, Germany.

From INTEGRA Biosciences 19 Mar 2015

AbbVie signs exclusive worldwide license agreement with C2N for Alzheimer's disease therapies

AbbVie today announced that it has entered into an exclusive worldwide license agreement with C2N Diagnostics, a privately held protein diagnostic and therapeutic discovery company, to develop and commercialize a portfolio of anti-tau antibodies for the treatment of Alzheimer's Disease and other neurological disorders.

19 Mar 2015

Antech Diagnostics agrees to acquire assets of AVRL for $21 million from Abaxis

Abaxis, Inc., a medical products company manufacturing point-of-care blood analysis systems, and VCA Inc., a leading animal healthcare company in the United States and Canada, today jointly announced Antech Diagnostics, Inc., VCA's laboratory division, has agreed to acquire the assets of AVRL (Abaxis Veterinary Reference Laboratory) from Abaxis for $21 million in cash.

19 Mar 2015

Sigma-Aldrich, Roche sign distribution agreement for Biochemical Reagents products

Sigma-AldrichCorporation, a leading Life Science and Technology company, announced today it signed an exclusive global distribution agreement with Roche. The agreement pairs Roche's high-quality Biochemical Reagents product portfolio with the industry-leading eCommerce and supply chain capabilities of Sigma-Aldrich.

19 Mar 2015

Los Alamos scientists develop new method for metagenomic analysis

Scientists at Los Alamos National Laboratory have developed a new method for DNA analysis of microbial communities such as those found in the ocean, the soil, and our own guts.

19 Mar 2015

GenomeNext completes whole genome sequencing analysis at unprecedented 1,000 genomes per day

GenomeNext, LLC, a leader in genomic data management and integrated analysis, announced today that, through the "Intel Heads In The Clouds Challenge on Amazon Web Services" with support from JHC Technology, and in conjunction with Nationwide Children's Hospital, has benchmarked whole genome sequencing analysis at an unprecedented 1,000 genomes per day.

18 Mar 2015

Improving adherence to ulcerative colitis medications: an interview with Mattias Norrman, COO, Tillotts Pharma

The objective of the survey was two-sided. On one side, we wanted to better understand needs, concerns and attitudes of people with UC in an effort to identify solutions to improve the management of the disease. On the other, we wanted to build a questionnaire that could be used by HCPs to help define patients’ needs and concerns.

17 Mar 2015

Ludwig researchers establish proof of concept for new approach to drug design

Exploring the fundamental mechanism by which a cell-surface receptor transmits its signal, an international team of Ludwig researchers and their colleagues has established proof of concept for an entirely new approach to drug design. They report that a class of synthetic molecules known as diabodies can, from outside the cell, latch onto a target receptor and manipulate it in such a manner as to induce distinct and varying effects within cells and tissues.

17 Mar 2015

Medical experts aim to offer lifesaving treatments to eliminate preventable deaths from AKI by 2025

Preventable deaths caused by acute kidney injury (AKI) could be nearly eliminated in just 10 years, according to leading medical experts. This often forgotten condition - which affects around 13 million people every year and contributes to 1.7 million deaths annually - is preventable and can be treated for as little as $US150 per patient.

17 Mar 2015

NantWorks, Sorrento collaborate to discover and develop novel anti-cancer immunotherapies

NantWorks, Inc. and Sorrento Therapeutics, Inc., announced today that they have entered into a binding agreement to initiate a global collaboration to discover and develop novel anti-cancer immunotherapies derived from Sorrento's proprietary G-MAB library against neoepitopes of tumor-specific antigens discovered using NantWorks' proprietary pan-omics based, precision medicine approach.

16 Mar 2015

Fast and focused sequencing from single genes to entire exomes

Integrated DNA Technologies (IDT) will host a talk on maximizing efficiency of NGS enrichment panels at the qPCR & NGS 2015 Advanced Molecular Diagnostics for Biomarker Discovery Symposium on Monday March 23rd at 3PM. The talk will detail current technical issues faced by researchers when using hybridization enrichment panels and provide practical advice on how to increase successes while reducing time and costs in targeted sequencing.

From Integrated DNA Technologies 16 Mar 2015

Diagnostics News and Research

Rigontec raises €4.8 million in second closing of Series A financing round

Researchers use genetic information to track the fatal spread of multidrug-resistant TB

Scientists use DNA sequencing to trace the spread of drug-resistant TB

Newly identified proteins could shed light on the mechanisms of ALS

Association for Molecular Pathology submits written comments to FDA on NGS regulation

Globavir, BioManguinhos partner to jointly evaluate PanGlob RT-PCR Dengue diagnostic assay

Genomic Health presents 11 studies demonstrating value of Oncotype DX breast cancer test

MEDITE announces granting of German priority patent for Histology 'Lab-in-one Automation' System

Sandia biosciences technologies could soon find their way into doctors' offices

INTEGRA Biosciences announces opening of German subsidiary

AbbVie signs exclusive worldwide license agreement with C2N for Alzheimer's disease therapies

Antech Diagnostics agrees to acquire assets of AVRL for $21 million from Abaxis

Sigma-Aldrich, Roche sign distribution agreement for Biochemical Reagents products

Los Alamos scientists develop new method for metagenomic analysis

GenomeNext completes whole genome sequencing analysis at unprecedented 1,000 genomes per day

Improving adherence to ulcerative colitis medications: an interview with Mattias Norrman, COO, Tillotts Pharma

Ludwig researchers establish proof of concept for new approach to drug design

Medical experts aim to offer lifesaving treatments to eliminate preventable deaths from AKI by 2025

NantWorks, Sorrento collaborate to discover and develop novel anti-cancer immunotherapies

Fast and focused sequencing from single genes to entire exomes

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News